Effect of Circadian Light on Hospitalized Persons With Dementia and Older Adults With Cognitive Impairments.

NCT05535790 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-09-10

No results posted yet for this study

Summary

Light stimulates the human visual system and the biological functions in the retina, also referred to as non-visual responses, e.g. hormone production. Exposure to the correct light composition can produce acute alertness and increase good sleep quality (1).

In this study, subjects will be exposed to 24-hour LED naturalistic lighting (intervention) or traditional lighting (control) during all days of hospitalization. Subjects will be blinded to the intervention as they will not be told if they are admitted to an intervention patient room or a control patient room.

The primary outcome measure is cortisol levels measured in saliva samples. Secondary outcome measures are delirium rates, length of admission, use of constant observation, mortality and adverse advent.

It is estimated that 80 subjects will be included in the study.

Conditions

Interventions

OTHER

Naturalistic LED light

Naturalistic LED light (bright light therapy) which affects Melanopic Equivalent Daylight Illuminance.

OTHER

Standard/traditional lighting

Standard/tradtional lighting environment with fluorescent tubes

Sponsors & Collaborators

  • Technical University of Denmark

    collaborator OTHER
  • University of Copenhagen

    collaborator OTHER
  • Zealand University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2024-01-01
Completion
2024-05-01

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05535790 on ClinicalTrials.gov